Advanced search
Publication Cover
Drug Development and Industrial Pharmacy Volume 35, 2009 - Issue 8
Submit an article Journal homepage
242
Views
18
CrossRef citations to date
0
Altmetric
Original Article

Quantification of compaction-induced crystallinity reduction of a pharmaceutical solid using 19F solid-state NMR and powder X-ray diffraction

Jodi Liu Small Molecule Pharmaceutical R&D, Amgen Inc., One Amgen Center Drive, Thousand Oaks, CA, USA
,
Karthik Nagapudi Small Molecule Pharmaceutical R&D, Amgen Inc., One Amgen Center Drive, Thousand Oaks, CA, USA
,
Y.-H. Kiang Small Molecule Pharmaceutical R&D, Amgen Inc., One Amgen Center Drive, Thousand Oaks, CA, USACorrespondence[email protected]
,
Ezequiel Martinez Small Molecule Pharmaceutical R&D, Amgen Inc., One Amgen Center Drive, Thousand Oaks, CA, USA
&
Janan Jona Small Molecule Pharmaceutical R&D, Amgen Inc., One Amgen Center Drive, Thousand Oaks, CA, USA
Pages 969-975 | Received 21 Jul 2008, Accepted 05 Jan 2009, Published online: 19 May 2009

References

  • Yu L. (2001). Amorphous pharmaceutical solids: Preparation, characterization and stabilization. Adv Drug Deliv Rev, 48(1):27–42.
  • Hancock BC, Zografi G. (1997). What is the true solubility advantage for amorphous pharmaceuticals?. J Pharm Sci, 86(1):1–12.
  • Nakai Y, Fukuoka E, Nakajima S, Hasegawa J. (1977). Crystallinity and physical characteristics of microcrystalline cellulose. Chem Pharm Bull, 25(1):96–101.
  • Pikal MJ, Lukes AL, Lang JE, Gaines K. (1978). Quantitative crystallinity determinations for beta-lactam antibiotics by solution calorimetry: Correlations with stability. J Pharm Sci, 67(6):767–73.
  • Saleki-Gerhardt A, Ahlneck C, Zografi G. (1994). Assessment of disorder in crystalline solids. Int J Pharm, 101(3):237–47.
  • York P. (1983). Solid-state properties of powders in the formulation and processing of solid dosage forms. Int J Pharm, 14(1):1–28.
  • Ahlneck C, Zografi G. (1990). The molecular basis of moisture effects on the physical and chemical stability of drugs in the solid state. Int J Pharm, 62(2–3):87–95.
  • Burt HM, Mitchell AG. (1981). Crystal defects and dissolution. Int J Pharm, 9(2):137–52.
  • Klug HP, Alexander LE. (1974). X-ray diffraction procedures for polycrystalline and amorphous materials . New York: Wiley.
  • Buckton G, Darcy P. (1999). Assessment of disorder in crystalline powders—A review of analytical techniques and their application. Int J Pharm, 179(2):141–58.
  • Shah B, Kakumanu VK, Bansal AK. (2006). Analytical techniques for quantification of amorphous/crystalline phases in pharmaceutical solids. J Pharm Sci, 95(8):1641–65.
  • Harris RK. (2007). Applications of solid-state NMR to pharmaceutical polymorphism and related matters. J Pharm Pharmacol, 59(2):225–39.
  • Tishmack PA, Bugay DE, Byrn SR. (2003). Solid-state nuclear magnetic resonance spectroscopy—pharmaceutical applications. J Pharm Sci, 92(3):441–74.
  • Gustafsson C, Lennholm H, Iverson T, Nystrom C. (1998). Comparison of solid-state NMR and isothermal microcalorimetry in the assessment of the amorphous content of lactose. Int J Pharm, 174(1–2):243–52.
  • Lefort R, De Gusseme A, Willart JF, Danede F, Descamps M. (2004). Solid state NMR and DSC methods for quantifying the amorphous content in solid dosage forms: An application to ball-milling of trehalose. Int J Pharm, 280(1–2):209–19.
  • Offerdahl TJ, Salsbury JS, Dong Z, Grant DJ, Schroeder SA, Prakash I, (2005). Quantitation of crystalline and amorphous forms of anhydrous neotame using 13C CPMAS NMR spectroscopy. J Pharm Sci, 94(12):2591–605.
  • Wenslow RM. (2002). 19F solid-state NMR spectroscopic investigation of crystalline and amorphous forms of a selective muscarinic M3 receptor antagonist, in both bulk and pharmaceutical dosage form samples. Drug Dev Ind Pharm, 28(5):555–61.
  • Aujla RS, Harris RK, Packer KJ, Parameswaran M, Say BJ, Bunn A, (1982). Discriminatory experiments in high-resolution 13C NMR of solid polymers. Polym Bull ; 8:253–9.
  • Thompson P, Cox DE, Hastings JB. (1987). Rietveld refinement of Debye-Scherrer synchrotron X-ray data from alumina. J Appl Crystallogr, 20(2):79–83.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.